CHM Price sensitive 1 Jun 2026, 8:27 AM

CHM announces positive Phase 1/2 data at ASCO

Chimeric Therapeutics Ltd

Open PDF

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.